17 December 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.

12 December 2024 -- Cambridge, UK -- electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10 Jan in Las Vegas, USA.

11 December 2024 -- Tramore, Republic of Ireland -- Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland.

11 December 2024 -- Liege, Belgium -- Allegro NV, a biomedical company developing transformative nanotechnology-based devices for degenerative joint disease, today announced that its injectable microparticle gel, hydrocelin, has demonstrated favorable safety in two preclinical studies.

10 December 2024 -- Maryland, US -- Sapio Sciences, the science-aware lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025.

10 December 2024 -- London, UK -- The Pistoia Alliance has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center) on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI regulations on cross-border research collaboration (85%).

www.biotechshowcase.com

www.interphex.com

All the single cells

The contents page for IPT Winter 2024

Seeing out 2024, IPT Winter shows no sign of slowing down for the holiday season – with many featured companies looking steadfastly into 2025 and all that next year may hold.

https://www.terrapinn.com/FLABS/IPT